<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37903272</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>45</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>07</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Dysregulated CD200-CD200R signaling in early diabetes modulates microglia-mediated retinopathy.</ArticleTitle><Pagination><StartPage>e2308214120</StartPage><MedlinePgn>e2308214120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2308214120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2308214120</ELocationID><Abstract><AbstractText>Diabetic retinopathy (DR) is a neurovascular complication of diabetes. Recent investigations have suggested that early degeneration of the neuroretina may occur prior to the appearance of microvascular changes; however, the mechanisms underlying this neurodegeneration have been elusive. Microglia are the predominant resident immune cell in the retina and adopt dynamic roles in disease. Here, we show that ablation of retinal microglia ameliorates visual dysfunction and neurodegeneration in a type I diabetes mouse model. We also provide evidence of enhanced microglial contact and engulfment of amacrine cells, ultrastructural modifications, and transcriptome changes that drive inflammation and phagocytosis. We show that CD200-CD200R signaling between amacrine cells and microglia is dysregulated during early DR and that targeting CD200R can attenuate high glucose-induced inflammation and phagocytosis in cultured microglia. Last, we demonstrate that targeting CD200R in vivo can prevent visual dysfunction, microglia activation, and retinal inflammation in the diabetic mouse. These studies provide a molecular framework for the pivotal role that microglia play in early DR pathogenesis and identify a potential immunotherapeutic target for treating DR in patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pfeifer</LastName><ForeName>Charles W</ForeName><Initials>CW</Initials><Identifier Source="ORCID">0000-0002-7579-2984</Identifier><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences Graduate Program, Roy and Diana Vagelos Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santeford</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7691-6213</Identifier><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Joseph B</ForeName><Initials>JB</Initials><Identifier Source="ORCID">0000-0001-6667-9018</Identifier><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences Graduate Program, Roy and Diana Vagelos Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beatty</LastName><ForeName>Wandy L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terao</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6182-4343</Identifier><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo 1138665, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yizhou A</ForeName><Initials>YA</Initials><Identifier Source="ORCID">0000-0002-3067-7042</Identifier><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hase</LastName><ForeName>Keitaro</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-4131-7509</Identifier><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruzycki</LastName><ForeName>Philip A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0003-3520-6407</Identifier><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apte</LastName><ForeName>Rajendra S</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0003-2281-2336</Identifier><AffiliationInfo><Affiliation>John F. Hardesty, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Developmental Biology, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 EY002687</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 EY013360</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EY019287</GrantID><Acronym>EY</Acronym><Agency>NEI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F30 DK130282</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007200</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002345</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C492346">CD200 receptor, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>UQ4V77A8VA</RegistryNumber><NameOfSubstance UI="C042739">antigens, CD200</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="Y">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003930" MajorTopicYN="Y">Diabetic Retinopathy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012160" MajorTopicYN="N">Retina</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diabetes</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">microglia</Keyword><Keyword MajorTopicYN="N">retina</Keyword><Keyword MajorTopicYN="N">retinopathy</Keyword></KeywordList><CoiStatement>Washington University St. Louis may file intellectual property related to these discoveries on which R.S.A. and C.W.P. are listed as inventors.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37903272</ArticleId><ArticleId IdType="pmc">PMC10636339</ArticleId><ArticleId IdType="doi">10.1073/pnas.2308214120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Flaxman S. R., et al. , Global causes of blindness and distance vision impairment 1990&#x2013;2020: A systematic review and meta-analysis. Lancet Global Health 5, e1221&#x2013;e1234 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29032195</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi P., et al. , Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pra ct. 157, 107843 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31518657</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Lo A., Diabetic retinopathy: Pathophysiology and treatments. IJMS 19, 1816 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6032159</ArticleId><ArticleId IdType="pubmed">29925789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn E. H., et al. , Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc. Natl. Acad. Sci. U.S.A. 113, E2655&#x2013;E2664 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868487</ArticleId><ArticleId IdType="pubmed">27114552</ArticleId></ArticleIdList></Reference><Reference><Citation>Abcouwer S. F., Gardner T. W., Diabetic retinopathy: Loss of neuroretinal adaptation to the diabetic metabolic environment. Ann. N.Y. Acad. Sci. 1311, 174&#x2013;190 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4154702</ArticleId><ArticleId IdType="pubmed">24673341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kern T. S., Berkowitz B. A., Photoreceptors in diabetic retinopathy. J. Diabetes Invest. 6, 371&#x2013;380 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4511295</ArticleId><ArticleId IdType="pubmed">26221514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinclair S. H., Schwartz S. S., Diabetic retinopathy&#x2013;an underdiagnosed and undertreated inflammatory, neuro-vascular complication of diabetes. Front. Endocrinol. 10, 843 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6923675</ArticleId><ArticleId IdType="pubmed">31920963</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerani A., et al. , Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab. 18, 505&#x2013;518 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24093675</ArticleId></ArticleIdList></Reference><Reference><Citation>Honasoge A., Nudleman E., Smith M., Rajagopal R., Emerging insights and interventions for diabetic retinopathy. Curr. Diab Rep. 19, 100 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7941754</ArticleId><ArticleId IdType="pubmed">31506830</ArticleId></ArticleIdList></Reference><Reference><Citation>Duh E. J., Sun J. K., Stitt A. W., Diabetic retinopathy: Current understanding, mechanisms, and treatment strategies. JCI Insight 2, e93751 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5518557</ArticleId><ArticleId IdType="pubmed">28724805</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva P. S., Sun J. K., Aiello L. P., Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy. Seminars Ophthalmol. 24, 93&#x2013;99 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19373693</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolinger M., Antonetti D., Moving past anti-VEGF: Novel therapies for treating diabetic retinopathy. IJMS 17, 1498 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5037775</ArticleId><ArticleId IdType="pubmed">27618014</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Yang P., Kijlstra A., Distribution, markers, and functions of retinal microglia. Ocular Immunol. Inflamm. 10, 27&#x2013;39 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12461701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., et al. , Requirement for microglia for the maintenance of synaptic function and integrity in the mature retina. J. Neurosci. 36, 2827&#x2013;2842 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4879218</ArticleId><ArticleId IdType="pubmed">26937019</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlstetter M., Ebert S., Langmann T., Microglia in the healthy and degenerating retina: Insights from novel mouse models. Immunobiology 215, 685&#x2013;691 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20573418</ArticleId></ArticleIdList></Reference><Reference><Citation>Paolicelli R. C., et al. , Microglia states and nomenclature: A field at its crossroads. Neuron 110, 3458&#x2013;3483 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9999291</ArticleId><ArticleId IdType="pubmed">36327895</ArticleId></ArticleIdList></Reference><Reference><Citation>De Biase L. M., et al. , Local cues establish and maintain region-specific phenotypes of basal ganglia microglia. Neuron 95, 341&#x2013;356.e6 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754189</ArticleId><ArticleId IdType="pubmed">28689984</ArticleId></ArticleIdList></Reference><Reference><Citation>Colton C. A., Heterogeneity of microglial activation in the innate immune response in the brain. J. Neuroimmune Pharmacol. 4, 399&#x2013;418 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2773116</ArticleId><ArticleId IdType="pubmed">19655259</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren-Shaul H., et al. , A unique microglia type associated with restricting development of Alzheimer&#x2019;s disease. Cell 169, 1276&#x2013;1290.e17 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28602351</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond T. R., et al. , Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity 50, 253&#x2013;271.e6 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6655561</ArticleId><ArticleId IdType="pubmed">30471926</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L., et al. , Microglial phagocytosis of living photoreceptors contributes to inherited retinal degeneration. EMBO Mol. Med. 7, 1179&#x2013;1197 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4568951</ArticleId><ArticleId IdType="pubmed">26139610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng H., et al. , Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest. Ophthalmol. Vis. Sci. 46, 2992 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16043876</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Koren E. G., et al. , Microglial function is distinct in different anatomical locations during retinal homeostasis and degeneration. Immunity 50, 723&#x2013;737.e7 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6592635</ArticleId><ArticleId IdType="pubmed">30850344</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng X.-X., Ng Y.-K., Ling E.-A., Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis. Neurosci. 17, 463&#x2013;471 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10910112</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng H., Microglial activation in human diabetic retinopathy. Arch Ophthalmol. 126, 227 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18268214</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y., et al. , Retinal astrocytes and microglia activation in diabetic retinopathy rhesus monkey models. Curr. Eye Res. 47, 297&#x2013;303 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34547966</ArticleId></ArticleIdList></Reference><Reference><Citation>Grigsby J. G., et al. , The role of microglia in diabetic retinopathy. J. Ophthalmol. 2014, 1&#x2013;15 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4166427</ArticleId><ArticleId IdType="pubmed">25258680</ArticleId></ArticleIdList></Reference><Reference><Citation>Church K. A., et al. , Microglia depletion elicits neuroprotective effects to alleviate vascular damage and neuronal cell loss in the diabetic retina. J. Immunol. 208, 54.14-54.14 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H., Chen M., Diabetic retinopathy and dysregulated innate immunity. Vision Res. 139, 39&#x2013;46 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28571700</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;bsam A., Parikh S., Fort P., Role of inflammation in diabetic retinopathy. IJMS 19, 942 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5979417</ArticleId><ArticleId IdType="pubmed">29565290</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrentino F. S., Allkabes M., Salsini G., Bonifazzi C., Perri P., The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy. Life Sci. 162, 54&#x2013;59 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27497914</ArticleId></ArticleIdList></Reference><Reference><Citation>Rungger-Br&#xe4;ndle E., Dosso A. A., Leuenberger P. M., Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 41, 1971&#x2013;1980 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10845624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zong H., et al. , Hyperglycaemia-induced pro-inflammatory responses by retinal M&#xfc;ller glia are regulated by the receptor for advanced glycation end-products (RAGE). Diabetologia 53, 2656&#x2013;2666 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20835858</ArticleId></ArticleIdList></Reference><Reference><Citation>Su F., Yi H., Xu L., Zhang Z., Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro. Neuroscience 294, 60&#x2013;68 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25711936</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam D., Lively S., Schlichter L. C., Responses of rat and mouse primary microglia to pro- and anti-inflammatory stimuli: Molecular profiles, K+ channels and migration. J. Neuroinflamm. 14, 166 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5567442</ArticleId><ArticleId IdType="pubmed">28830445</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui T. A., Lively S., Schlichter L. C., Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia. J. Neuroinflamm. 13, 66 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4806433</ArticleId><ArticleId IdType="pubmed">27009332</ArticleId></ArticleIdList></Reference><Reference><Citation>Brucklacher R. M., et al. , Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med Genomics 1, 26 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2442612</ArticleId><ArticleId IdType="pubmed">18554398</ArticleId></ArticleIdList></Reference><Reference><Citation>Furman B. L., Streptozotocin-induced diabetic models in mice and rats. Curr. Protoc. 1, 5.47.1&#x2013;5.47.20 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">26331889</ArticleId></ArticleIdList></Reference><Reference><Citation>Sergeys J., et al. , Longitudinal in vivo characterization of the streptozotocin-induced diabetic mouse model: Focus on early inner retinal responses. Invest. Ophthalmol. Vis. Sci. 60, 807 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30811545</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dijk H. W., et al. , Selective loss of inner retinal layer thickness in Type 1 diabetic patients with minimal diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 50, 3404 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2937215</ArticleId><ArticleId IdType="pubmed">19151397</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng J., Zou Q., Chen M.-J., Ma C.-L., Li B.-M., Motor deficits seen in microglial ablation mice could be due to non-specific damage from high dose diphtheria toxin treatment. Nat. Commun. 13, 3874 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9256727</ArticleId><ArticleId IdType="pubmed">35790742</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei F., et al. , CSF1R inhibition by a small-molecule inhibitor is not microglia specific; affecting hematopoiesis and the function of macrophages. Proc. Natl. Acad. Sci. U.S.A. 117, 23336&#x2013;23338 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519218</ArticleId><ArticleId IdType="pubmed">32900927</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruttger J., et al. , Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system. Immunity 43, 92&#x2013;106 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26163371</ArticleId></ArticleIdList></Reference><Reference><Citation>Pardue M. T., et al. , Rodent hyperglycemia-induced inner retinal deficits are mirrored in human diabetes. Trans. Vis. Sci. Tech. 3, 6 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4064622</ArticleId><ArticleId IdType="pubmed">24959388</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachtmeister L., Oscillatory potentials in the retina: What do they reveal. Prog. Retinal Eye Res. 17, 485&#x2013;521 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9777648</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai J., et al. , Contribution of GABAa, GABAc and glycine receptors to rat dark-adapted oscillatory potentials in the time and frequency domain. Oncotarget 8, 77696&#x2013;77709 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5652335</ArticleId><ArticleId IdType="pubmed">29100418</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastinger M. J., Singh R. S. J., Barber A. J., Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and ins2 Akita -diabetic mouse retinas. Invest. Ophthalmol. Vis. Sci. 47, 3143 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16799061</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.-H., et al. , Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 46, 1260&#x2013;1268 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12898017</ArticleId></ArticleIdList></Reference><Reference><Citation>Okunuki Y., et al. , Microglia inhibit photoreceptor cell death and regulate immune cell infiltration in response to retinal detachment. Proc. Natl. Acad. Sci. U.S.A. 115, E6264&#x2013;E6273 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6142210</ArticleId><ArticleId IdType="pubmed">29915052</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisht K., et al. , Dark microglia: A new phenotype predominantly associated with pathological states. Glia 64, 826&#x2013;839 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4949554</ArticleId><ArticleId IdType="pubmed">26847266</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson J. R., et al. , Exploring the retinal connectome. Mol. Vis 17, 355&#x2013;379 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3036568</ArticleId><ArticleId IdType="pubmed">21311605</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa C., et al. , Single-cell transcriptomics reveals distinct inflammation-induced microglia signatures. EMBO Rep. 19, e46171 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6216255</ArticleId><ArticleId IdType="pubmed">30206190</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I. M., et al. , A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 4, 385&#x2013;401 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills S. A., et al. , Fractalkine-induced microglial vasoregulation occurs within the retina and is altered early in diabetic retinopathy. Proc. Natl. Acad. Sci. U.S.A. 118, e2112561118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8713803</ArticleId><ArticleId IdType="pubmed">34903661</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillaumond F., et al. , Kr&#xfc;ppel-like factor KLF10 is a link between the circadian clock and metabolism in liver. Mol. Cell. Biol. 30, 3059&#x2013;3070 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2876690</ArticleId><ArticleId IdType="pubmed">20385766</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabello-Aguilar S., et al. , SingleCellSignalR: Inference of intercellular networks from single-cell transcriptomics. Nucleic Acids Res. 48, e55&#x2013;e55 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261168</ArticleId><ArticleId IdType="pubmed">32196115</ArticleId></ArticleIdList></Reference><Reference><Citation>Oria M., et al. , CD200-CD200R imbalance correlates with microglia and pro-inflammatory activation in rat spinal cords exposed to amniotic fluid in retinoic acid-induced spina bifida. Sci. Rep. 8, 10638 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6045622</ArticleId><ArticleId IdType="pubmed">30006626</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S., et al. , CD200-CD200R1 signaling pathway regulates neuroinflammation after stroke. Brain Behav. 10, e01882 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7749562</ArticleId><ArticleId IdType="pubmed">33067924</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotwica-Mojzych K., Jod&#x142;owska-J&#x119;drych B., Mojzych M., CD200:CD200R interactions and their importance in immunoregulation. IJMS 22, 1602 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7915401</ArticleId><ArticleId IdType="pubmed">33562512</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., et al. , CD200Fc reduces TLR4-mediated inflammatory responses in LPS-induced rat primary microglial cells via inhibition of the NF-&#x3ba;B pathway. Inflamm. Res. 65, 521&#x2013;532 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26956766</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernang&#xf3;mez M., et al. , CD200R1 agonist attenuates glial activation, inflammatory reactions, and hypersensitivity immediately after its intrathecal application in a rat neuropathic pain model. J. Neuroinflamm. 13, 43 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4759712</ArticleId><ArticleId IdType="pubmed">26891688</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannucci J., Rao H. V., Grammas P., High glucose and hypoxia-mediated damage to human brain microvessel endothelial cells induces an altered, pro-inflammatory phenotype in BV-2 microglia in vitro. Cell Mol. Neurobiol. 42, 985&#x2013;996 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8942976</ArticleId><ArticleId IdType="pubmed">33136275</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J., Hua L., Harmer D., Li P., Ren G., &#x201c;Cre driver mice targeting macrophages&#x201d; in Methods in Molecular Biology, Rousselet G., Ed. (Springer, New York, 2018), pp. 263&#x2013;275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6331202</ArticleId><ArticleId IdType="pubmed">29761406</ArticleId></ArticleIdList></Reference><Reference><Citation>Beli E., et al. , CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes. J. Mol. Med. 94, 1255&#x2013;1265 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5071129</ArticleId><ArticleId IdType="pubmed">27344677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokomizo H., et al. , Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy. Sci. Transl. Med. 11, eaau6627 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7132633</ArticleId><ArticleId IdType="pubmed">31270273</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto K., et al. , Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. U.S.A. 96, 10836&#x2013;10841 (1999).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC17969</ArticleId><ArticleId IdType="pubmed">10485912</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivares A. M., et al. , Animal models of diabetic retinopathy. Curr. Diab. Rep. 17, 93 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5569142</ArticleId><ArticleId IdType="pubmed">28836097</ArticleId></ArticleIdList></Reference><Reference><Citation>Like A. A., Rossini A. A., Streptozotocin-induced pancreatic insulitis: New model of diabetes mellitus. Science 193, 415&#x2013;417 (1976).</Citation><ArticleIdList><ArticleId IdType="pubmed">180605</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin P. M., Roon P., Van Ells T. K., Ganapathy V., Smith S. B., Death of retinal neurons in streptozotocin-induced diabetic mice. Invest. Ophthalmol. Vis. Sci. 45, 3330 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15326158</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferro A., Auguste Y. S. S., Cheadle L., Microglia, cytokines, and neural activity: Unexpected interactions in brain development and function. Front. Immunol. 12, 703527 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8281303</ArticleId><ArticleId IdType="pubmed">34276699</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden M., Grant D., Aroor A., DeMarco V., Ultrastructural remodeling of the neurovascular unit in the female diabetic db/db model-part II: Microglia and mitochondria. Neuroglia 1, 311&#x2013;326 (2018).</Citation></Reference><Reference><Citation>El Hajj H., et al. , Ultrastructural evidence of microglial heterogeneity in Alzheimer&#x2019;s disease amyloid pathology. J. Neuroinflamm. 16, 87 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6469225</ArticleId><ArticleId IdType="pubmed">30992040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh C.-F., Liu C.-K., Lee C.-T., Yu L.-E., Wang J.-Y., Acute glucose fluctuation impacts microglial activity, leading to inflammatory activation or self-degradation. Sci. Rep. 9, 840 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351546</ArticleId><ArticleId IdType="pubmed">30696869</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan Y., Jiang C., Xue B., Zhu S., Wang X., High glucose stimulates TNF&#x3b1; and MCP-1 expression in rat microglia via ROS and NF-&#x3ba;B pathways. Acta Pharmacol. Sin 32, 188&#x2013;193 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4009937</ArticleId><ArticleId IdType="pubmed">21293471</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv K., et al. , Integrated multi-omics reveals the activated retinal microglia with intracellular metabolic reprogramming contributes to inflammation in STZ-induced early diabetic retinopathy. Front. Immunol. 13, 942768 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9479211</ArticleId><ArticleId IdType="pubmed">36119084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolliniati O., Ieronymaki E., Vergadi E., Tsatsanis C., Metabolic regulation of macrophage activation. J. Innate Immun. 14, 51&#x2013;68 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8787535</ArticleId><ArticleId IdType="pubmed">34247159</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehla K., Singh P. K., Metabolic regulation of macrophage polarization in cancer. Trends Cancer 5, 822&#x2013;834 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187927</ArticleId><ArticleId IdType="pubmed">31813459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunnon K., et al. , Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration. J. Immunol. 186, 7215&#x2013;7224 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21572034</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., et al. , CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson&#x2019;s disease. J. Neuroinflamm. 8, 154 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3226566</ArticleId><ArticleId IdType="pubmed">22053982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyons A., et al. , CD200 ligand-receptor interaction modulates microglial activation in vivo and in vitro: A role for IL-4. J. Neurosci. 27, 8309&#x2013;8313 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673084</ArticleId><ArticleId IdType="pubmed">17670977</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick C., et al. , Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol. 161, 1669&#x2013;1677 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1850781</ArticleId><ArticleId IdType="pubmed">12414514</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor S., et al. , Involvement of the CD200 receptor complex in microglia activation in experimental glaucoma. Exp. Eye Res. 92, 338&#x2013;343 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3650638</ArticleId><ArticleId IdType="pubmed">21296076</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., et al. , CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis. J. Neurosci. 30, 2025&#x2013;2038 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2837938</ArticleId><ArticleId IdType="pubmed">20147531</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeifer C. W., Apte R. S., RNA-seq of STZ-treated mouse retinal microglia cells. Gene Expression Omnibus. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE222005. Deposited 2 January 2023.</Citation></Reference><Reference><Citation>Pfeifer C. W., Apte R. S., RNA-seq of BV2 cultured microglia following high glucose and CD200Fc treatments. Gene Expression Omnibus. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE238008. Deposited 21 July 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>